| Frank D. Shin, Md, Inc | |
|
1440 S De Anza Blvd Suite A San Jose CA 95129-4666 | |
| (408) 366-0405 | |
| Not Available |
| Full Name | Frank D. Shin, Md, Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1440 S De Anza Blvd, San Jose, California |
| Authorized Official Name and Position | Frank Da Shin (CEO) |
| Authorized Official Contact | 4083660405 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Frank D. Shin, Md, Inc 1440 S Deanza Blvd Suite A San Jose CA 95129 Ph: (408) 366-0405 | Frank D. Shin, Md, Inc 1440 S De Anza Blvd Suite A San Jose CA 95129-4666 Ph: (408) 366-0405 |
| NPI Number | 1013104488 |
|---|---|
| Provider Enumeration Date | 10/01/2007 |
| Last Update Date | 06/15/2011 |
| Medicare PECOS PAC ID | 8426040411 |
|---|---|
| Medicare Enrollment ID | O20040331000689 |
News Archive
Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
N-Viro International Corporation, a leading-edge environmental biotech company that markets an alternative fuel technology and advanced fertilizer products, including the renewable biofuel N-Viro Fuel™ and N-Viro Soil™, announced that on May 17, 2010 it filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2010.
A new study published in the latest issue of Biological Psychiatry reports the successful and instant reduction of fear in spider-fearful participants following a 2-minute exposure combined with a single dose of a regular pharmacological treatment.
Gastrointestinal stromal tumors are the most common mesenchymal tumors of the digestive tract. However, the duodenal location is less common. Nowadays, surgery is still the only curative approach for GIST. Numerous procedures can be performed to remove duodenal GIST. Some of these operations are extensive and require difficult reconstruction (like pancreaticoduodenectomy; PD). One of the options is a more limited intervention: segmental duodenectomy.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013104488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | G80006 (California) | Primary |
| Provider Name | Frank Da Shin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003992264 PECOS PAC ID: 3779483094 Enrollment ID: I20040405001737 |
News Archive
Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
N-Viro International Corporation, a leading-edge environmental biotech company that markets an alternative fuel technology and advanced fertilizer products, including the renewable biofuel N-Viro Fuel™ and N-Viro Soil™, announced that on May 17, 2010 it filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2010.
A new study published in the latest issue of Biological Psychiatry reports the successful and instant reduction of fear in spider-fearful participants following a 2-minute exposure combined with a single dose of a regular pharmacological treatment.
Gastrointestinal stromal tumors are the most common mesenchymal tumors of the digestive tract. However, the duodenal location is less common. Nowadays, surgery is still the only curative approach for GIST. Numerous procedures can be performed to remove duodenal GIST. Some of these operations are extensive and require difficult reconstruction (like pancreaticoduodenectomy; PD). One of the options is a more limited intervention: segmental duodenectomy.
› Verified 2 days ago
News Archive
Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
N-Viro International Corporation, a leading-edge environmental biotech company that markets an alternative fuel technology and advanced fertilizer products, including the renewable biofuel N-Viro Fuel™ and N-Viro Soil™, announced that on May 17, 2010 it filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2010.
A new study published in the latest issue of Biological Psychiatry reports the successful and instant reduction of fear in spider-fearful participants following a 2-minute exposure combined with a single dose of a regular pharmacological treatment.
Gastrointestinal stromal tumors are the most common mesenchymal tumors of the digestive tract. However, the duodenal location is less common. Nowadays, surgery is still the only curative approach for GIST. Numerous procedures can be performed to remove duodenal GIST. Some of these operations are extensive and require difficult reconstruction (like pancreaticoduodenectomy; PD). One of the options is a more limited intervention: segmental duodenectomy.
› Verified 2 days ago
Chris Chung, Md, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 455 Oconnor Dr, #150, San Jose, CA 95128 Phone: 408-293-7767 Fax: 408-294-6595 | |
Tuan Le, M.d. A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1569 Lexann Ave, Suite 122, San Jose, CA 95121 Phone: 408-531-1555 | |
Verity Medical Foundation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 227 N Jackson Ave, San Jose, CA 95116 Phone: 408-278-3000 | |
Leena Gupta Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4945 Bridgeview Ln, San Jose, CA 95138 Phone: 408-666-0392 | |
Shen Medicine & Pediatrics Assc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 316 Rosewood Ave, San Jose, CA 95117 Phone: 408-296-9800 Fax: 408-296-9805 | |
Terry C. Lin D.o.,inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2520 Samaritan Dr., #201, San Jose, CA 95124 Phone: 888-582-0814 |